A look back at decades of brain tumor trials from two research groups
Original title: The evolution of RTOG and NRG Oncology CNS tumors clinical trials.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a summary of past studies, not a new treatment result.
The short version
This paper looks back at how large brain tumor studies have shaped the care patients get today.
What was studied. Experts reviewed past studies run by two big research groups, RTOG and NRG Oncology. The studies were in adults with brain tumors, including gliomas, tumors that spread to the brain, meningiomas, and brain lymphoma.
What they found. Early studies helped set how much radiation to give and how to give it. Later studies showed that stronger treatment often did not help more, and they helped make chemo with radiation a standard for gliomas. For tumors that spread to the brain, studies moved care toward focused radiation and ways to protect memory and thinking.
What this means, and what it doesn't
What it could mean: Much of the care used today for adult brain tumors came from studies like these. Newer studies are now looking at treatment based on each tumor's genes.
What it doesn't mean: This is a review of past studies, not a new result. It does not bring a new treatment. It is not a promise of a cure. Your own care should still be planned with your doctor.
Source: PubMed, September 15, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.